Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer

NCT00038428 is registered in ClinicalTrials.gov with Telik as lead sponsor.

NCT NCT00038428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00038428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer
Lead sponsor
Telik
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2001
Completion date
July 31, 2005
Enrollment
40
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian neoplasms